Work

PLGA Microparticles Encapsulating Prostaglandin E1-Hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) Complex for the Treatment of Pulmonary Arterial Hypertension (PAH)

Year: 2011

Type: article

Source: Pharmaceutical Research

DOI: 10.1007/s11095-011-0409-6

Authors: Vivek Gupta, Marauo Davis, Louisa J. Hope-Weeks, Fakhrul Ahsan

Institutions: Texas Tech University Health Sciences Center, Texas Tech University

Language: English

Topic: Inhalation and Respiratory Drug Delivery

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Food and Drug Administration, National Heart, Lung, and Blood Institute

Award: Anti-PAH Drugs in Inhalable Nanoparticles for Sustained Pulmonary Vasodilation

OpenAlex ID: W2142997746

FWCI: 3.535

Cites: 50

Cited by: 55

Related to: 10